G. Pugh et al., Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate, and clofibrate in cynomolgus monkeys, TOXICOL SCI, 56(1), 2000, pp. 181-188
The effects of the peroxisome proliferators di-isononyl phthalate (DINP) an
d di-2-ethylhexyl phthalate (DEHP) were evaluated in young adult male cynom
olgus monkeys after 14 days of treatment, with emphasis on detecting hepati
c and other effects seen in rats and mice after treatment with high doses o
f phthalates. Groups of 4 monkeys received DINP (500 mg/kg/day), DEHP (500
mg/kg/day), or vehicle (0.5% methyl cellulose, 10 ml/kg) by intragastric in
tubation for 14 consecutive days. Clofibrate (250 mg/kg/day), a hypolipidem
ic drug used for cholesterol reduction in human patients was used as a refe
rence substance. None of the test substances had any effect on body weight
or liver weights. Histopathological examination of tissues from these anima
ls revealed no distinctive treatment-related effects in the liver, kidney,
or testes. There were also no changes in any of the hepatic markers for per
oxisomal proliferation, including peroxisomal beta-oxidation (PBOX) or repl
icative DNA synthesis. Additionally, in situ dye transfer studies using fre
sh liver slices revealed that DINP, DEHP, and clofibrate had no effect on g
ap junctional intercellular communication (GJIC). None of the test substanc
es produced any toxicologically important changes in urinalysis, hematology
, or clinical chemistry; however, clofibrate produced some emesis, small in
creases in serum triglyceride, decreased calcium, and decreased weights of
testes/epididymides and thyroid/parathyroid. The toxicological significance
of these small changes is questionable. The absence of observable hepatic
effects in monkeys at doses that produce hepatic effects in rodents suggest
s that DINP, DEHP, and clofibrate would also not elicit in primates other e
ffects such as liver cancer. These data, along with results from in vitro h
epatocyte studies, indicate that rodents are not good animal models for pre
dicting the hepatic effects of phthalates in primates, including humans.